Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3272643 | Journal de Gynécologie Obstétrique et Biologie de la Reproduction | 2014 | 10 Pages |
Abstract
Review of the current literature favors the use of vaginal misoprostol 25 μg three- to six-hourly equally to dinoprostone accordingly with previous French and international guidelines (World Health Organization and American College of Obstetricians and Gynecologist). The use of misoprostol 25 μg supposes a preparation by the pharmacist to ensure the safety of this precise posology. Medico-economic studies are warranted to attest an economic benefice to the use of misoprostol 25 μg in comparison to dinoprostone.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
A. Gaudineau, C. Vayssière,